91 – 100 of 163
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Limitations of Antinuclear Antibody Tests (HEp-2) Are Overcome with the Autoimmune Target Test (IT-1) in Systemic Lupus Erythematosus Reply
- Contribution to journal › Letter
-
Mark
Perturbed Insulin-like Growth Factor-1 (IGF-1) and IGF Binding Protein-3 Are Not Associated with Chronic Widespread Pain in Men: Results from the European Male Ageing Study.
- Contribution to journal › Article
-
Mark
Differences in Longitudinal Disease and Treatment Characteristics of Patients with Rheumatoid Arthritis Replying and Not Replying to a Postal Questionnaire. Experience from a Biologics Register in Southern Sweden.
- Contribution to journal › Article
-
Mark
Six and 12 Weeks Treatment Response Predicts Continuation of Tumor Necrosis Factor Blockade in Rheumatoid Arthritis: An Observational Cohort Study from Southern Sweden.
- Contribution to journal › Article
- 2008
-
Mark
Improved Lupus Outcome. We Are Doing a Good Job, But Could We Do Better?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clustering of extraarticular manifestations in patients with rheumatoid arthritis
- Contribution to journal › Letter
-
Mark
Abnormal Antinuclear Antibody Titers Are Less Common Than Generally Assumed in Established Cases of Systemic Lupus Erythematosus.
- Contribution to journal › Article
-
Mark
The Swedish Early Psoriatic Arthritis Register -- 2-year Followup: A Comparison with Early Rheumatoid Arthritis.
- Contribution to journal › Article
-
Mark
Socioeconomic and occupational risk factors for rheumatoid arthritis : a nationwide study based on hospitalizations in Sweden
- Contribution to journal › Article
- 2007
-
Mark
Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties
- Contribution to journal › Article
